2024.04.03 Notification.

ArayaNewly launched "NeuroHatch," a new service to support neuroscience research.

Strengthening research support systems for all phases of brain science research.

Araya( CEO, Minato-ku, Tokyo; President: Ryota Kanai; hereinafter " Araya"), which provides research and R&D support for artificial intelligence (AI) and neuroscience, has renewed its neuroscience research support service for start-up client companies and research institutions as "NeuroHatch" ( *1) and will now offer more extensive services. The service has been renewed as "NeuroHatch" (*1) and is now available with enhanced services and content.

URL: https://www.araya.org/service/neurotech/

 In recent years, research and product development using information obtained from living organisms has accelerated in various business fields, including the development of neurotech solutions and products with bio-sensing functions, elucidation of brain functions, and development of treatments for brain-derived diseases ( *2). This service has already been used by 14 corporate research institutes and 14 universities and research institutions, and researchers and medical doctors with expertise in neuroscience and bio-sensing have contributed to the acceleration of research and development in various fields, including the elucidation of brain functions and the development of treatments for brain-derived diseases, by using advanced analysis technology and the latest knowledge. NeuroHatch provides brain data such as EEG and MRI, analysis of biological data such as heartbeat, respiration, and perspiration, optimal test design, and algorithm development based on the data to corporate laboratories and research institutes that wish to promote R&D and product development utilizing brain science and biological sensing. We provide strong support for all stages of product development utilizing neuroscience research and physiological indices, from analysis of brain data such as EEG and MRI, and biological data such as heart rate, respiration, and perspiration, to the development of algorithms based on the data.
 With this renewal, we have introduced the latest analysis methods and strengthened our service delivery system. This will support the research and development of companies and research institutions more speedily and effectively, and accelerate the implementation of innovative technologies in society. The main services offered by NeuroHatch are as follows

Data Analysis Support:
  Analysis of brain data and biological data such as EEG, MRI, PET, etc., using AI and the latest methods and knowledge.

Study design:
  We support the smooth implementation of studies by selecting optimal subjects, proposing measurement methods, and creating study protocols according to research objectives.

Data Acquisition:
  Acquisition of high quality brain and biological data by professional staff. We also support the acquisition of in-house data acquisition skills.

AI algorithm development/implementation support:
  Support for development of AI algorithms using acquired data and implementation in programmed medical devices, etc.

Service Web site URL:.
https://www.araya.org/service/neurotech/

Through NeuroHatch, we will continue to leverage our expertise in neuroscience and bioengineering to provide multifaceted support for the social implementation of technological seeds from companies and research institutions.

[ CEOCEO Ryota Kanai comments
Brain neuroscience has the potential to bring about major breakthroughs in the fields of medicine and product development. NeuroHatch was created to fill this gap. We strongly support the research and development of companies and research institutions by making full use of our expertise in brain science and bio-sensing, as well as the latest analysis technology. Through NeuroHatch, we hope to discover neuroscience-related technological seeds and nurture them to a level where they can be implemented in society, thereby realizing both economic value and scientific significance at the same time. We hope to realize both economic value and scientific significance at the same time.

(*1) "Hatch" means "to incubate. Through "NeuroHatch," we aim to discover neuroscience-related technology seeds that lie dormant in companies and universities, create value from the R&D stage, and nurture them to a level where they can be implemented in society, thereby making the world an overwhelmingly interesting place.

(*2) The global neurotech market is worth US$12.82 billion in 2022, at a CAGR of 11.53% (2022-2032) (President Research), the biosensing market is worth US$28.44 billion in 2023, at a CAGR of 7.9% (2024-2033) (President Research), and the software as a medical device (SaMD) market is worth US$1.43579 billion in 2022, at a CAGR of 40.05% (2022-2033) (President Research). (2033) (President Research), and the software as a medical device (SaMD) market size is US$ 1,435.79 million (2022), CAGR 40.05% (2022 - 2023) (INDUSTRY RESEARCH).

Company Profile

Company name: Kabushiki Kaisha, Ltd. Araya
Representative: CEORyota Kanai
Established: December 2013
Location: 6F Sanpo Sakuma Building, 1-11 Kandasakumacho, Chiyoda-ku, Tokyo
URL: https://www.araya.org/
Business: Deep Learning, Edge AI, Autonomous AI, Neurotech, Contract Research

PDF FILE

For inquiries regarding this press release, please contact

Ltd. ArayaPublic Relations: Asai, Michibayashi
Home Page :https://www.araya.org/
e-mail: support@araya.org